Apogee Therapeutics, Inc. (APGE)
NASDAQ: APGE · Real-Time Price · USD
37.63
+0.79 (2.14%)
At close: Sep 17, 2025, 4:00 PM EDT
38.11
+0.48 (1.28%)
After-hours: Sep 17, 2025, 6:55 PM EDT
Apogee Therapeutics Market Cap
Apogee Therapeutics has a market cap or net worth of $2.20 billion as of September 17, 2025. Its market cap has decreased by -21.34% in one year.
Market Cap
2.20B
Enterprise Value
1.59B
1-Year Change
-21.34%
Ranking
Category
Stock Price
$37.63
Market Cap Chart
Since the IPO on July 14, 2023, Apogee Therapeutics's market cap has increased from $808.89M to $2.20B, an increase of 172.47%. That is a compound annual growth rate of 58.44%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2025 | 2.16B | -16.29% |
| Dec 31, 2024 | 2.58B | 92.13% |
| Dec 29, 2023 | 1.34B | 65.86% |
| Jul 14, 2023 | 808.89M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 671.68B |
| Johnson & Johnson | 427.24B |
| AbbVie | 384.42B |
| UnitedHealth Group | 315.07B |
| Novo Nordisk | 248.69B |
| AstraZeneca | 240.71B |
| Novartis AG | 238.00B |
| Abbott Laboratories | 228.57B |